DNA

CirrusMD and Tendo Partner to Expand Choice and Savings for Employees and Their Dependents 

CirrusMD adds Tendo CareConnect Marketplace to provide more affordable, high-quality care options for patients needing in-person careDENVER and PHILADELPHIA, Jan.…

1 year ago

Foresight Diagnostics Provides 2025 Outlook and 2024 Year in Review

- Achieved 100% revenue growth versus prior year – - Received Investigational Device Exemption approval from the FDA for the…

1 year ago

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications

Software upgrade advances complete workflow solutions New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X,…

1 year ago

Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma

Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI).The partnership with…

1 year ago

Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)

MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), an emerging leader in age-reversal science…

1 year ago

Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization

WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it…

1 year ago

CORRECTION – OraQuick® HIV Self-Test Now Approved for Use in Adolescents

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th…

1 year ago

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

CUPERTINO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage…

1 year ago

Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on…

1 year ago

Erisyon Awarded $2.2M Grant to Develop Diagnostic for Immuno-Oncology Treatment Selection

AUSTIN, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Erisyon, a leading provider of single-molecule proteomics technology, today announced that it…

1 year ago